Received Mar 24, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 2 | Unknown | PO / MO |
The patient took the second dose of Vivotif 72 hours later; The patient did not wait until one hour for eat food, five minutes later of taking Vivotif patient ate food; Case reference number US-BN-2024-002831 is a spontaneous case initially received from a pharmacist via Med Communications (reference number: USBAV24-3183) on 03-Dec-2024 and concerns a 72-years-old female patient. The patient's medical history and concomitant medication details were not provided. On 29-Nov-2024, the patient took first dose of Vivotif (batch number: unknown), at unknown dose, orally, for indication typhoid immunization. On an unspecified date, reported as 72 hours later, the patient took the second dose of Vivotif vaccine (batch number: unknown), at unknown dose, orally (explicitly coded as 'inappropriate schedule of vaccine administered'). As reported the patient did not wait until one hour for eating food, five minutes later of taking Vivotif patient ate food (explicitly coded as 'product administration error'). At the time of the initial report, it was unknown if the patient experienced any adverse event due to Vivotif. Non-significant follow up was downloaded from VAERS on 09-May-2025 included new reference number. Administrative update performed within the case: Worldwide Unique Case Identification Number (WWID) updated from US-20241203-b62982 to US-BAVARIAN NORDIC A/S-US-BN-2024-002831, in accordance with ICH guidance on WWID formatting.; Reporter's Comments: A 72-years-old female patient took first dose of Vivotif on 29-Nov-2024, at unknown dose, orally, for indication typhoid immunization. Reportedly, five minutes after taking Vivotif patient ate food which is considered as product administration error. Inappropriate schedule of product administration and product administration error are both considered listed per company conventions. At this point, it was unknown if the patient experienced any adverse event due to Vivotif. The patient's medical history and concomitant medication details were not provided. Inappropriate schedule of product administration and product administration error are both assessed as not related to suspect product but to human factor. The case is non-serious.; Sender's Comments: A 72-years-old female patient took first dose of Vivotif on 29-Nov-2024, at unknown dose, orally, for indication typhoid immunization. Reportedly, five minutes after taking Vivotif patient ate food which is considered as product administration error. Inappropriate schedule of product administration and product administration error are both considered listed per company conventions. At this point, it was unknown if the patient experienced any adverse event due to Vivotif. The patient's medical history and concomitant medication details were not provided. Inappropriate schedule of product administration and product administration error are both assessed as not related to suspect product but to human factor. The case is non-serious. USBAV24-3183:
Comments: None.